Axon Enterprise, Inc $AXON Shares Acquired by Stonebridge Financial Group LLC

Stonebridge Financial Group LLC increased its holdings in Axon Enterprise, Inc (NASDAQ:AXONFree Report) by 285.1% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 389 shares of the biotechnology company’s stock after acquiring an additional 288 shares during the quarter. Stonebridge Financial Group LLC’s holdings in Axon Enterprise were worth $322,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of AXON. TCTC Holdings LLC lifted its stake in shares of Axon Enterprise by 75.0% in the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after acquiring an additional 24 shares in the last quarter. Bartlett & CO. Wealth Management LLC increased its holdings in Axon Enterprise by 132.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock valued at $31,000 after buying an additional 33 shares during the last quarter. Banque Transatlantique SA bought a new stake in Axon Enterprise in the first quarter valued at about $31,000. Catalyst Capital Advisors LLC bought a new stake in Axon Enterprise in the first quarter valued at about $32,000. Finally, Flaharty Asset Management LLC bought a new stake in Axon Enterprise in the first quarter valued at about $33,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Activity at Axon Enterprise

In related news, CFO Brittany Bagley sold 5,000 shares of the stock in a transaction that occurred on Monday, September 29th. The stock was sold at an average price of $713.88, for a total value of $3,569,400.00. Following the completion of the transaction, the chief financial officer directly owned 93,592 shares of the company’s stock, valued at $66,813,456.96. This represents a 5.07% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Jeffrey C. Kunins sold 7,891 shares of the stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $750.10, for a total value of $5,919,039.10. Following the completion of the transaction, the insider directly owned 144,538 shares of the company’s stock, valued at $108,417,953.80. This trade represents a 5.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 59,932 shares of company stock valued at $45,115,616. 4.40% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. Zacks Research lowered Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 2nd. JMP Securities reissued a “market outperform” rating and issued a $825.00 price objective on shares of Axon Enterprise in a report on Monday, September 29th. Wolfe Research assumed coverage on Axon Enterprise in a report on Monday, July 7th. They issued an “outperform” rating for the company. Northland Securities set a $800.00 price objective on Axon Enterprise in a report on Tuesday, August 5th. Finally, Bank of America boosted their price objective on Axon Enterprise from $895.00 to $1,000.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. Fourteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $841.64.

Check Out Our Latest Stock Report on AXON

Axon Enterprise Stock Down 4.2%

NASDAQ:AXON opened at $703.03 on Friday. The firm has a market capitalization of $55.19 billion, a PE ratio of 173.59, a price-to-earnings-growth ratio of 28.50 and a beta of 1.41. The stock has a 50 day moving average of $755.57 and a 200-day moving average of $712.63. Axon Enterprise, Inc has a 52 week low of $422.38 and a 52 week high of $885.91. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63.

Axon Enterprise (NASDAQ:AXONGet Free Report) last posted its earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating the consensus estimate of $1.54 by $0.58. The company had revenue of $668.54 million during the quarter, compared to analyst estimates of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business’s revenue was up 32.6% compared to the same quarter last year. During the same period in the prior year, the company earned $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. Analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Stories

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.